Sarcoma  >>  robatumumab (SCH 717454)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
robatumumab (SCH 717454) / Merck (MSD)
NCT00617890 / 2007-005341-38: A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)

Terminated
2
219
NA
robatumumab, SCH 717454, SCH 717454 (19D12), MK-7454
Merck Sharp & Dohme LLC
Osteosarcoma, Sarcoma, Ewing's, Peripheral Neuroectodermal Tumor
08/11
08/13

Download Options